These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 23157999

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Two cases of risperidone-induced neuroleptic malignant syndrome.
    Singer S, Richards C, Boland RJ.
    Am J Psychiatry; 1995 Aug; 152(8):1234. PubMed ID: 7542838
    [No Abstract] [Full Text] [Related]

  • 3. Risperidone-induced neuroleptic malignant syndrome.
    Webster P, Wijeratne C.
    Lancet; 1994 Oct 29; 344(8931):1228-9. PubMed ID: 7523815
    [No Abstract] [Full Text] [Related]

  • 4. Risperidone-induced neuroleptic malignant syndrome in young patient.
    Raitasuo V, Vataja R, Elomaa E.
    Lancet; 1994 Dec 17; 344(8938):1705. PubMed ID: 7527886
    [No Abstract] [Full Text] [Related]

  • 5. Two cases of risperidone-induced neuroleptic malignant syndrome.
    Dave M.
    Am J Psychiatry; 1995 Aug 17; 152(8):1233-4. PubMed ID: 7542837
    [No Abstract] [Full Text] [Related]

  • 6. Effects of concomitant risperidone and lithium treatment.
    Swanson CL, Price WA, McEvoy JP.
    Am J Psychiatry; 1995 Jul 17; 152(7):1096. PubMed ID: 7540798
    [No Abstract] [Full Text] [Related]

  • 7. Paliperidone-associated atypical neuroleptic malignant syndrome: a case report.
    Han C, Lee SJ, Pae CU.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar 30; 35(2):650-1. PubMed ID: 21163319
    [No Abstract] [Full Text] [Related]

  • 8. Neuroleptic malignant syndrome associated with risperidone long-acting injection: a case report.
    Yamashita T, Fujii Y, Misawa F.
    J Clin Psychopharmacol; 2013 Feb 30; 33(1):127-9. PubMed ID: 23288234
    [No Abstract] [Full Text] [Related]

  • 9. Possible neuroleptic malignant syndrome during paliperidone administration: a case report.
    Mantas C, Kalabokis G, Goulia P, Tourlakopoulos A, Hyphantis T, Mavreas V.
    J Clin Psychopharmacol; 2010 Feb 30; 30(1):89-91. PubMed ID: 20075663
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Citrome L, Meng X, Hochfeld M, Stahl SM.
    Hum Psychopharmacol; 2012 Jan 30; 27(1):24-32. PubMed ID: 22161738
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Neuroleptic malignant syndrome in users of risperidone].
    Bonte-Mineur F, Geerlings CJ, Rietveld AP.
    Ned Tijdschr Geneeskd; 2005 Jan 15; 149(3):158-9; author reply 159. PubMed ID: 15693595
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
    Liu PY, Wu PC, Chen CY, Chen YC.
    Gen Hosp Psychiatry; 2011 Jan 15; 33(1):84.e5-7. PubMed ID: 21353143
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia.
    Mané A, Baeza I, Morer A, Lázaro ML, Bernardo M.
    J Child Adolesc Psychopharmacol; 2005 Dec 15; 15(6):844-5. PubMed ID: 16379503
    [No Abstract] [Full Text] [Related]

  • 18. Iloperidone for the management of adults with schizophrenia.
    Crabtree BL, Montgomery J.
    Clin Ther; 2011 Mar 15; 33(3):330-45. PubMed ID: 21600386
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Neuroleptic malignant syndrome.
    Bhattacharyya K.
    J Assoc Physicians India; 1999 Sep 15; 47(9):940. PubMed ID: 10778680
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.